2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Retrospective Study of Germ Cell Tumors of the Central Nervous Systemcentral nervous system germ cell tumorActive, not recruitingNot stated2024-10-15NCT05836701
Camrelizumab for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL)primary central nervous system lymphomaRecruitingPhase 22024-10-15NCT04070040